Literature DB >> 21739483

Occurrence of Aurora A positive multipolar mitoses in distinct molecular classes of colorectal carcinomas and effect of Aurora A inhibition.

Corinna Herz1, Fabienne Schlürmann, Daniela Batarello, Christiane D Fichter, Anja Schöpflin, Claudia Münch, Dieter Hauschke, Martin Werner, Silke Lassmann.   

Abstract

Aurora A "over-"expression may induce supernumerary centrosomes, respective multipolar mitoses, and aneuploidy. Here, we examined Aurora A positive multipolar mitoses in aneuploid, microsatellite-stable (MSS, "CIN-type") versus near-diploid, microsatellite-instable (MSI, "MIN-type") colorectal carcinomas (CRC) and CRC cell lines as well as the effect of Aurora A inhibition in CRC cell lines. In situ, three-dimensional immunofluorescence (3D-IF) revealed Aurora A positive multipolar mitoses in both CIN- (n = 8) and MIN- (n = 10) type primary CRCs with similar frequencies (CIN: 27 ± 14%; MIN: 34 ± 14%, P = 0.224). In vitro, Aurora A positive multipolar mitoses were detected in asynchronized or thymidine synchronized CIN-type (HT29, CaCo-2), but not MIN-type (HCT116, DLD-1) CRC cells. Nocodazole treatment arrested mitotic cells with multiple centrosomal Aurora A signals in CIN- and MIN-type CRC cells, albeit to a lower extent in CaCo-2 cells. This was associated with concomitant activation of Aurora A (T288 phosphorylation) and Polo-like kinase 1 (PLK-1, T210 phosphorylation). Aurora A inhibition by siRNA resulted in increased apoptosis (>50%) in all cell lines, but did not abolish PLK-1 expression. Double 3D-IF revealed that Aurora A siRNA treated, still viable CIN-type (HT29, CaCo-2) CRC cells were Aurora A negative and mostly in prophase/(pro)metaphase with maintained phosphorylated PLK-1 T210 expression. Aurora A positive multipolar mitoses occur in both aneuploid, CIN- and near-diploid MIN-type CRCs. This appears to be largely independent of Aurora A expression alone. Although Aurora A inhibition causes apoptosis in both CIN- and MIN-type CRC cells, remaining PLK-1 activation by other factors may affect therapeutic Aurora inhibition.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21739483     DOI: 10.1002/mc.20823

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  4 in total

1.  Aurora B expression and histone variant H1.4S27 phosphorylation are no longer coordinated during metaphase in aneuploid colorectal carcinomas.

Authors:  Fahima Sijare; Anna-Lena Geißler; Christiane D Fichter; Sonja P Hergeth; Lioudmila Bogatyreva; Dieter Hauschke; Robert Schneider; Martin Werner; Silke Lassmann
Journal:  Virchows Arch       Date:  2015-02-14       Impact factor: 4.064

2.  Histone modifiers and marks define heterogeneous groups of colorectal carcinomas and affect responses to HDAC inhibitors in vitro.

Authors:  Lisa Lutz; Ingrid Coutiño Fitzner; Theresa Ahrens; Anna-Lena Geißler; Frank Makowiec; Ulrich T Hopt; Lioudmila Bogatyreva; Dieter Hauschke; Martin Werner; Silke Lassmann
Journal:  Am J Cancer Res       Date:  2016-02-15       Impact factor: 6.166

3.  Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations.

Authors:  M M Koczorowska; S Tholen; F Bucher; L Lutz; J N Kizhakkedathu; O De Wever; U F Wellner; M L Biniossek; A Stahl; S Lassmann; O Schilling
Journal:  Mol Oncol       Date:  2015-08-11       Impact factor: 6.603

4.  Protein kinase C zeta suppresses low- or high-grade colorectal cancer (CRC) phenotypes by interphase centrosome anchoring.

Authors:  Ravi Kiran Deevi; Arman Javadi; Jane McClements; Jekaterina Vohhodina; Kienan Savage; Maurice Bernard Loughrey; Emma Evergren; Frederick Charles Campbell
Journal:  J Pathol       Date:  2018-03-09       Impact factor: 7.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.